作者: Mark Shearman , Mervyn Turner
DOI:
关键词:
摘要: There is disclosed the use of a compound formula (I): or pharmaceutically acceptable salt thereof, for manufacture medicament treatment age-related cognitive decline mild impairment, in particular with view to preventing delaying onset Alzheimer's disease.